Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2369-2375

  Ciernik, I Frank ^a,c   Berzofsky, Jay A ^b   Carbone, David P ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFER; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; DNA; ENDOPLASMIC RETICULUM; EPITOPES; FEMALE; GENES, P53; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 0029878034     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88:991.
2. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 342: 1531.
3. Aichele, P., D. Kyburz, P. S. Ohashi, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1994. Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 91:444.
4. + T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res. 54:4155.
5. Shafferman, A., M. Lewis, F. McCutchan, R. Benveniste, P. Jahrling, R. Hickman, C. Lai, D. Burke, and G. Eddy. 1992. Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission. AIDS Res. Hum. Retroviruses 8:1483.
6. Rowland-Jones, S. L., R. E. Phillips, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael. 1992. Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS Res. Hum. Retroviruses 8:1353.
7. Phillips, R. E., and A. J. McMichael. 1993. How does the HIV escape cytotoxic T cell immunity? Chem. Immunol. 56:150.
8. Udhayakumar, V., Y. P. Shi, S. Kumar, D. L. Jae, R. M. Wohlhueter, and A. A. Lal. 1994. Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition. Infect. Immun. 62:1410.
9. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183.
10. Carbone, F., and M. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
11. Ishioka, G. Y., S. Colon, C. Miles, H. M. Grey, and R. W. Chesnut. 1989. Induction of class I MHC-restricted, peptide-specific cytotoxic T cells by peptide priming in vivo. J. Immunol. 143:1094.
12. Deres, K., H. Schild, K.-H. Wiesmüller, G. Jung, and H.-G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
13. Gupta, R. K., E. H. Relyveld, E. B. Lindblad, B. Bizzani, S. Ben-Efraim, and C. Kanta Gupta. 1993. Adjuvants: a balance between toxicity and adjuvanticity. Vaccine 11:293.
14. Romero, P., J.-C. Cerottini, and I. Luescher. 1994. Efficient in vivo induction of CTL by cell-associated covalent H-2Kd-peptide complexes. J. Immunol. Methods 171:73.
15. Berzofsky, J. A. 1993. Epitope Selection and design of synthetic vaccines: molecular approaches to enhancing immunogenecity and crossreactivity of engineered vaccines. Ann. NY Acad. Sci. 690:256.
16. Tang, D., M. DeVit, and S. A. Johnston. 1992. Genetic immunization: a simple method for eliciting an immune response. Nature 356:152.
17. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and. M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
18. Eisenbraun, M. D., D. Heydenburg Fuller, and J. R. Haynes. 1993. Examination of parameters affecting the eliction of humoral immune response by particle bombardment-mediated genetic immunization. DNA Cell. Biol. 12:791.
19. Wang, B., K. E. Ugen, V. Srikantan, M. G. Agadjanyan, K. Dang, Y. Refaeli, A. I. Sato, J. Boyer, W. V. Williams, and D. B. Weiner. 1993. Gene inoculation generates immune response against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:4156.
20. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunization by parental, mucosal and gene-gun inoculation. Proc. Natl. Acad. Sci. USA 90:11478.
21. Chiba, I., T. Takahashi, M. M. Nau, D. D'Amico, D. Curiel, T. Mitsudomi, D. Buchhagen, D. Carbone, H. Koga, P. T. Reissmann, D. J. Slamon, E. C. Holmes, and J. D. Minna. 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603.
22. Johnston, S. A., and D.-C. Tang. 1993. The use of microparticle injection to introduce genes into animal cells in vitro and in vivo. In Genetic Engineering. Vol. 15, J. K. Setlow, ed. Plenum Press, New York, p. 225-236.
23. Takahashi, H., R. Houghten, S. Putney, D. Margulies, B. Moss, R. Germain, and J. Berzofsky. 1989. Structural requirements for class-I MHC molecule-mediated antigen presentation and cytotoxic T-cell recognition of an immunodominant determinant of the HIV envelope protein. J. Exp. Med. 170:2023.
24. + cytotoxic T cells. Cancer Res. 53:3257.
25. Ciernik, I. F., J. A. Berzofsky, and D. P. Carbone. 1995. Mutant oncopeptide immunization induces CTL specifically lysing tumor cells endogenously expressing the corresponding intact mutant p53. Hybridoma 14:139.
26. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. L. Cornette, C. DeLisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 83:3105.
27. + CTL by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunology 5:849.
28. Roberts, D. J., A. G. Craig, A. R. Berendt, R. Pinches, G. Nash, K. Marsh, and C. I. Newbold. 1992. Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357:689.
29. Saul, A., R. Lord, G. L. Jones, and L. Spencer. 1992. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J. Immunol. 148:208.
30. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfecied Gambian women. Nature Medicine 1:59.
31. Kast, W. M., L. Roux, J. Curren, H. J. Blom A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
32. Wang, B., J. Boyer, V. Srikantan, L. Coney, R. Carrano, C. Phan, M. Merva, K. Dang, M. Agadjanan, L. Gilbert, K. E. Ugen, W. V. Williams, and D. B. Weiner. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol. 12:799.
33. Okuda, K., H. Bukawa, K. Hamajima, S. Kawamoto, K.-I. Sekigawa, Y. Yamada, S.-I. Tanaka, N. Ishii, I. Aoki, M. Nakamura, H. Yamamoto, B. R. Cullen, and J. Fukushima. 1993. Induction of potent humoral and cell-mediated immune response following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res. Hum. Retroviruses 11:933.
34. Sodroski, J., W. C. Goh, C. Rosen, A. Dayton, E. Terwilliger, and W. Haseltine. 1986. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature 321:412.
35. Valmori, D., J. F. Romero, Y. Men, J. L. Maryanski, P. Romero, and G. Corradin. 1994. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Eur. J. Immunol. 24:1458.
36. + cytolytic T cells and confers protection to infection. Immunol. Lett. 40:101.
37. Gray, D., and P. Matzinger. 1991. T cell memory is short-lived in the absence of antigen. J. Exp. Med. 174:969.
38. Lutcke, H., S. High, K. Romisch, A. Ashford, and B. Dobberstein. 1992. The methionine-rich domain of the 54-kDa subunit of signal recognition particle is sufficient for the interaction with signal sequences. EMBO J. 11:1543.
39. High, S., and B. Dobberstein. 1992. Mechanisms that determine the transmembrane disposition of proteins. Curr Opin. Cell. Biol. 4:581.
40. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmatic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489.
41. Restifo, N. P., I. Bacik, K. R. Irvine, J. W. Yewdell, B. J. McCabe, R. W. Anderson, L. C. Eisenlohr, S. A. Rosenberg, and J. R. Bennik. 1995. Antigen processing in vivo and the elicitation of primary CTL reponses. J. Immunol. 154:4414.
42. + T cells. Proc. Natl. Acad. Sci. USA 91:3171.
43. Fenton, R. G., D. D. Taub, L. W. Kwak, M. R. Smith, and D. L. Longo. 1993. Cytotoxic T-cell response and in vivo protection against tumor cells harboring activated ras proto-oncogenes. J. Natl. Cancer Inst. 85:1294.